Venmax Drugs & Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 2.48 | 4.04 | 1.62 |
| Operating Expense | 2.36 | 3.93 | 1.58 |
| Net Profit | 0.12 | 0.11 | 0.03 |
| Net Profit Margin | 4.84% | 2.72% | 1.85% |
| Earning Per Share | 0.10 | 0.21 | 0.05 |
| EBIDTA | 0.12 | 0.11 | 0.04 |
| Effective Tax Rate | 0% | 0% | 25% |
Particulars
Jun 2026
Revenue2.48
Operating Expense2.36
Net Profit0.12
Net Profit Margin4.84
Earning Per Share0.10
EBIDTA0.12
Effective Tax Rate0
